Bones, joints and muscles
137 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| 4 in 1 block for lacerations | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| active FMT for axial spondyloarthritis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Active Whole-Body Hyperthermia (Active WBH) for hyperthermia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Adductor canal block for anterior cruciate ligament injuries | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Adductor canal block with IPACK for lacerations | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ALK-inhibitor or RET-inhibitor + BNT116 for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| aNPC for intervertebral disc degeneration | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| anti-HER3 antibody conjugated to topoisomerase I inhibitor + BNT116 for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Arthroscopic partial menisectomy + Postoperative rehabilitative physical therapy for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Autologous hematopoietic stem cell transplantation + BCMA CAR-T + GPRC5D/CD3 BiTEs for bites and stings | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Back Exosuit for musculoskeletal pain | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Back Exosuit for occupational injuries | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Berobenatide for osteoarthritis, knee | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT116 for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT116 + BNT316 for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT116 + CEMIPLIMAB for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT116 + CEMIPLIMAB + Carboplatin + Paclitaxel for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT116 + DOCETAXEL for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT116 + OSIMERTINIB for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT116 + Pumitamig for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT116 + Tambotatug Pelitecan for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT326 for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT326 + ITRACONAZOLE for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT326 + Paroxetine for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BNT326 + Pumitamig for arthrogryposis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bodycad Unicompartmental Knee System (BUKS) + Unicompartmental Knee Arthroplasty Surgery for osteoarthritis, knee | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bone marrow aspirate matrix for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bone marrow cell-based therapy & single-drug immunosuppression. + Deceased donor hand transplantation for amputation, traumatic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bone marrow cell-based therapy & single-drug immunosuppression. + Deceased donor hand transplantation for hand injuries | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet + Naproxen 500 Mg + Opioids for back injuries | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cementless Oxford Unicompartmental Knee Arthroplasty for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Classical wound irrigation (control) for wounds and injuries | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cognitive Behavioral Therapy (CBT) for hyperthermia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cognitive Behavioral Therapy (CBT) + Whole-Body Hyperthermia for hyperthermia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Continuous sciatic PNB for lacerations | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Control for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Doxycycline for osteoarthritis | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Duloxetine for musculoskeletal pain | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| dynamic contrast enhanced MRI + geniculate artery embolization for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ecnoglutide for osteoarthritis, knee | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Eloralintide for osteoarthritis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| embolization therapy for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Embosphere Microspheres for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Embozene MicroSpheres for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Embozene™ Microspheres + Transcatheter arterial embolization for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Essential Amino Acid Supplementation for femoral fractures | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Etanercept for acquired hyperostosis syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ethiodized Oil-based emulsion for osteoarthritis, knee | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Exercise for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Famotidine and 4% topical cromolyn sodium for burns | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fetoscopy for gastroschisis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fucosylated MSC for Osteoporosis for spinal fractures | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Furosemide for musculoskeletal pain | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Garetosmab for myositis ossificans | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Gel-Bead embolization for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| genicular artery embolisation for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| genicular artery embolisation for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| genicular artery embolization for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Genicular artery embolization (GAE) for osteoarthritis, knee | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Genicular Artery Embolization + Lipiodol for musculoskeletal pain | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Genicular Artery Embolization + Lipiodol for osteoarthritis, knee | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Genicular Nerve Block with bupivacaine and preservative free dexamethasone for anterior cruciate ligament injuries | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| geniculate artery embolization for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Geniculate Artery Embolization with Intra-articular Corticosteroid Injection (GAE with IACI) for musculoskeletal pain | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Geniculate Artery Embolization with Intra-articular Corticosteroid Injection (GAE with IACI) for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| GNA followed by GAE for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hand Transplantation for amputation, traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| High Tibial Osteotomy for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hydroxychloroquine sulfate for arthralgia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Inulin for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Iodine I-124 Evuzamitide for spinal stenosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| KJ101 for burns | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Modified delineation for radiation injuries | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Monoclonal Antibody (Humanized Anti-CD52) + Penile Allotransplantation + Tacrolimus for amputation, traumatic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Multiprofen-CC™ plus standard treatment for osteoarthritis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Navepegritide for achondroplasia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| NAVIO/CORI Surgical System for osteoarthritis | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Nile Tilapia Fish Skin for burns | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| NVDX3 for wrist fractures | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Opiate Sparing for anterior cruciate ligament injuries | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Orforglipron for osteoarthritis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ORG-34517 for wounds and injuries | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oxford + Unicompartment knee arthroplasty for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oxford unicompartmental knee arthroplasty for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Persona Partial Knee (PPK) for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo for myositis ossificans | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Platelet-Rich Plasma-Fibrin Glue for wounds and injuries | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Procellera for wounds and injuries | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Procellera® for burns | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Psilocybin for wounds and injuries | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Repairing Gel for wounds and injuries | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Repairing Gel and Platelet-Rich Plasma-Fibrin Glue for wounds and injuries | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Resistant Potato Starch for persian gulf syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for osteoarthritis, knee | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Rexlemestrocel-l for intervertebral disc degeneration | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Rexlemestrocel-L + HA mixture for intervertebral disc degeneration | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Rivogenlecleucel + rimiducid for osteopetrosis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Robot-assisted partial knee arthroplasty for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| SakuraBead Resorbable Microspheres for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SB-01 For Injection for intervertebral disc degeneration | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sigma hp partial knee for chondrocalcinosis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sigma hp partial knee for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Skin of Nile tilapia for burns | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Skin Xenotransplant for burns | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| SPY002-072 for axial spondyloarthritis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Structured Integrated Reframing Therapy (SIRT) for wounds and injuries | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Structured Integrated Reframing Therapy (SIRT) + Psilocybin for wounds and injuries | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Suzetrigine for hip fractures | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Suzetrigine for osteoarthritis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Suzetrigine for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Suzetrigine for rib fractures | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| the Terumo Hydropearl® microspheres device for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tissue Engineered Product for lacerations | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| TissueGene-C for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Total knee replacement for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| TPX-100 200mg, Once weekly for 4 weeks for osteoarthritis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tranexamic acid for anterior cruciate ligament injuries | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tranexamic acid for hemarthrosis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tranexamic acid for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Transarterial geniculate artery embolization for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Transcutaneous vagus nerve stimulation for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Transdermal estrogen for rotator cuff injuries | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| TREATMENT ARM: Full dose for wounds and injuries | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ultra-fractionated radiation therapy for radiation injuries | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ultrasound-guided Adductor Canal Block (ACB) + Ultrasound-guided iPACK block for anterior cruciate ligament injuries | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Unicompartmental Knee Arthroplasty (UKA) for osteoarthritis, knee | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Unicompartmental knee replacement for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Unicondylar Knee Arthroplasty for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Unicondylar Knee Replacement for osteoarthritis, knee | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vanguard M fixed-bearing or Oxford mobile-bearing prostheses for osteoarthritis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Varespladib methyl + varespladib for snake bites | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Visuospatial interference for wounds and injuries | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Visuospatial Task (VST) for wounds and injuries | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vosoritide for achondroplasia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 7 |
| Wbh for hyperthermia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Whole-Body Hyperthermia for hyperthermia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Whole-body hyperthermia + standard medical care for hyperthermia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |